GHP Biotechnology Awards 2024 forms the foundation of its operations, which it embodies by adhering to the ISO 9001:2015 quality management certification and working towards ISO 13485:2016. Responsibility drives every interaction the company has with its consumers and investors, enabling it to foster trust with them. Sustainability is also a key focus for Fethiann, so it plans to pursue a future aligned with its ESG vision. In order to ensure that all new recruits align with its existing values and culture, Fethiann carries out a question-and-answer session with candidates during the hiring process, assessing their familyresponsibility, self-responsibility, team-responsibility, and potential to contribute towards the wider company responsibility. Beyond hiring, Fethiann builds strong partnerships with its employees and periodically provides them with training to enhance their personal and professional skills. They undergo continuous improvement, ensuring their ability to keep up with the changing needs of the market. The company’s goal is to inspire and guide its staff, driving them to be their best selves. As a result, they are committed to their work and enjoy sharing Fethiann’s story with clients, answering any questions they may have about the company. Thanks to the remarkable work of its team, Fethiann has been awarded the title of Herb Extract Research Innovator of the Year, APAC, in the Biotechnology Awards 2024. In the years to come, the company plans to focus on meeting the expectations of its investors, becoming the world’s top supplier of patented key raw materials, and licencing patents to establish supply chain relationships with large pharmaceutical manufacturers. Furthermore, aiming to alleviate the devastating impacts of the recent Covid-19 pandemic, Fethiann’s future research will be centred around the protective effects of the different extracts from Magnolia Figo’s flowers and leaves on the respiratory damage caused by acute lung injury and allergic asthma. The goal is that this research project will enable FMO®️ to be applied as a preventive healthcare product or used to develop a new botanical drug for lung health and respiration system care. Contact: Frederic J. Kuo | CEO Company: Fethiann Molecule Applied Co., Ltd. Web Address: www.fethiannglobal.com
RkJQdWJsaXNoZXIy MTUyMDQwMA==